Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States
Rachel E. Patzer(Emory University), Stephen O. Pastan(Emory University), Heather Jones(Pennsylvania State University), Carlos Zayas(Prisma Health), Laura Plantinga(Emory University), Matthew J. Ellis(Washington University in St. Louis), Joshua H. Wolf(Piedmont HealthCare), Laura McPherson(Emory University), Sudeshna Paul(Emory University), Zhensheng Wang(Peng Cheng Laboratory), Derek A. DuBay(Medical University of South Carolina), Laura Mulloy(Augusta University), Amber Reeves‐Daniel(Atrium Health Wake Forest Baptist)
Cited by 94
Related Papers
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
|Journal of Clinical Oncology|2001|1.1k
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2010|823